Lutetium-177 DOTATATE (177Lu-DOTA-TATE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177 DOTATATE (177Lu-DOTA-TATE), covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. [Phase 1]